Huron Announces First Quarter 2026 Financial Results and Affirms Full Year 2026 Guidance
Huron reported Q1 2026 revenue before reimbursable expenses (RBR) of $443.7 million, up 12.1% year-over-year, driven by record performance in its Healthcare segment and solid growth in Commercial. Adjusted EBITDA surged 21.9% to $50.6 million, while adjusted diluted EPS rose 3.0% to $1.73, supported by margin expansion.
Key figures
- Eps
- 1.34
- Revenue
- $443.7 million
- Guidance
- FY2026 RBR $1.78B-$1.86B; Adjusted EBITDA margin 14.5%-15.0%; Adjusted EPS $8.35-$9.15
- Revenue Yoy
- 12.1%
- Adjusted eps
- 1.73
- Buyback value
- 155500000
- Adjusted ebitda
- $50.6 million
- Organic rbr growth
- 7.3%
- Shares repurchased
- 1114806
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.